Alpha Spread
Search stocks here...
Sign Up Log in
Dashboard Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator
Pricing Investing Ideas
Alpha Spread
Dashboard Tools Investing Ideas Pricing About Us
Sign Up
Log in
Alpha Spread
Dashboard Tools Investing Ideas Pricing About Us
Sign Up
Log in
Amryt Pharma Holdings Ltd Logo

Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Dividends
Investor Relations
Discount Rate
Price: 143 GBX -11.73% Market Closed
Market Cap: 457.1m GBX
Have any thoughts about
Amryt Pharma Holdings Ltd?
Write Note
Write Note Create Alert Ask AI
Add Note Why Create Notes?
Capture your thoughts
Note Buy Sell Hold Pass
US
Johnson & Johnson
NYSE:JNJ
Pharmaceuticals
US
Berkshire Hathaway Inc
NYSE:BRK.A
Financial Services
US
Bank of America Corp
NYSE:BAC
Banking
US
Mastercard Inc
NYSE:MA
Technology
US
UnitedHealth Group Inc
NYSE:UNH
Health Care
US
Exxon Mobil Corp
NYSE:XOM
Energy
US
Pfizer Inc
NYSE:PFE
Pharmaceuticals
US
Palantir Technologies Inc
NYSE:PLTR
Technology
US
Nike Inc
NYSE:NKE
Textiles, Apparel & Luxury Goods
US
Visa Inc
NYSE:V
Technology
CN
Alibaba Group Holding Ltd
NYSE:BABA
Retail
US
JPMorgan Chase & Co
NYSE:JPM
Banking
US
Coca-Cola Co
NYSE:KO
Beverages
US
Walmart Inc
NYSE:WMT
Retail
US
Verizon Communications Inc
NYSE:VZ
Telecommunication
US
Chevron Corp
NYSE:CVX
Energy


Add Price Alert
Price Target:
Last Price: 143 GBX

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch
Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?
Close
Back
Delete Note

Do you really want to delete this note?
This action cannot be undone.

Delete
Cancel
AMYT Alert
Amryt Pharma Holdings Ltd
143
-19 (-11.73%)
52 Week Range
N/A
N/A
Price Target

We'll email you a reminder when the closing price reaches GBX.

Save Alert

Choose the stock you wish to monitor with a price alert.

Johnson & Johnson
NYSE:JNJ
US
Berkshire Hathaway Inc
NYSE:BRK.A
US
Bank of America Corp
NYSE:BAC
US
Mastercard Inc
NYSE:MA
US
UnitedHealth Group Inc
NYSE:UNH
US
Exxon Mobil Corp
NYSE:XOM
US
Pfizer Inc
NYSE:PFE
US
Palantir Technologies Inc
NYSE:PLTR
US
Nike Inc
NYSE:NKE
US
Visa Inc
NYSE:V
US
Alibaba Group Holding Ltd
NYSE:BABA
CN
JPMorgan Chase & Co
NYSE:JPM
US
Coca-Cola Co
NYSE:KO
US
Walmart Inc
NYSE:WMT
US
Verizon Communications Inc
NYSE:VZ
US
Chevron Corp
NYSE:CVX
US
Delete Alert

This alert will be permanently deleted.

Delete
Cancel
Ask me anything about
Amryt Pharma Holdings Ltd

What unique competitive advantages
does Amryt Pharma Holdings Ltd hold over its rivals?

What risks and challenges
does Amryt Pharma Holdings Ltd face in the near future?

Provide an overview of the primary business activities
of Amryt Pharma Holdings Ltd.

Show me price targets
for Amryt Pharma Holdings Ltd made by professional analysts.

Provide an overview of the primary business activities
of Amryt Pharma Holdings Ltd.

What unique competitive advantages
does Amryt Pharma Holdings Ltd hold over its rivals?

What risks and challenges
does Amryt Pharma Holdings Ltd face in the near future?

Show all valuation multiples
for Amryt Pharma Holdings Ltd.

Provide P/S
for Amryt Pharma Holdings Ltd.

Provide P/E
for Amryt Pharma Holdings Ltd.

Provide P/OCF
for Amryt Pharma Holdings Ltd.

Provide P/FCFE
for Amryt Pharma Holdings Ltd.

Provide P/B
for Amryt Pharma Holdings Ltd.

Provide EV/S
for Amryt Pharma Holdings Ltd.

Provide EV/GP
for Amryt Pharma Holdings Ltd.

Provide EV/EBITDA
for Amryt Pharma Holdings Ltd.

Provide EV/EBIT
for Amryt Pharma Holdings Ltd.

Provide EV/OCF
for Amryt Pharma Holdings Ltd.

Provide EV/FCFF
for Amryt Pharma Holdings Ltd.

Provide EV/IC
for Amryt Pharma Holdings Ltd.

Show me price targets
for Amryt Pharma Holdings Ltd made by professional analysts.

What are the Revenue projections
for Amryt Pharma Holdings Ltd?

How accurate were the past Revenue estimates
for Amryt Pharma Holdings Ltd?

What are the Net Income projections
for Amryt Pharma Holdings Ltd?

How accurate were the past Net Income estimates
for Amryt Pharma Holdings Ltd?

What are the EPS projections
for Amryt Pharma Holdings Ltd?

How accurate were the past EPS estimates
for Amryt Pharma Holdings Ltd?

What are the EBIT projections
for Amryt Pharma Holdings Ltd?

How accurate were the past EBIT estimates
for Amryt Pharma Holdings Ltd?

Compare the revenue forecasts
for Amryt Pharma Holdings Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amryt Pharma Holdings Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amryt Pharma Holdings Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amryt Pharma Holdings Ltd compared to its peers.

Compare the P/E ratios
of Amryt Pharma Holdings Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Amryt Pharma Holdings Ltd with its peers.

Analyze the financial leverage
of Amryt Pharma Holdings Ltd compared to its main competitors.

Show all profitability ratios
for Amryt Pharma Holdings Ltd.

Provide ROE
for Amryt Pharma Holdings Ltd.

Provide ROA
for Amryt Pharma Holdings Ltd.

Provide ROIC
for Amryt Pharma Holdings Ltd.

Provide ROCE
for Amryt Pharma Holdings Ltd.

Provide Gross Margin
for Amryt Pharma Holdings Ltd.

Provide Operating Margin
for Amryt Pharma Holdings Ltd.

Provide Net Margin
for Amryt Pharma Holdings Ltd.

Provide FCF Margin
for Amryt Pharma Holdings Ltd.

Show all solvency ratios
for Amryt Pharma Holdings Ltd.

Provide D/E Ratio
for Amryt Pharma Holdings Ltd.

Provide D/A Ratio
for Amryt Pharma Holdings Ltd.

Provide Interest Coverage Ratio
for Amryt Pharma Holdings Ltd.

Provide Altman Z-Score Ratio
for Amryt Pharma Holdings Ltd.

Provide Quick Ratio
for Amryt Pharma Holdings Ltd.

Provide Current Ratio
for Amryt Pharma Holdings Ltd.

Provide Cash Ratio
for Amryt Pharma Holdings Ltd.

What is the historical Revenue growth
over the last 5 years for Amryt Pharma Holdings Ltd?

What is the historical Net Income growth
over the last 5 years for Amryt Pharma Holdings Ltd?

What is the current Free Cash Flow
of Amryt Pharma Holdings Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amryt Pharma Holdings Ltd.

Popular Prompts Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Profitability SummaryPast GrowthMarginsReturn on CapitalFree Cash FlowSee Also
Section:
Profitability Summary
Profitability Summary
Past Growth
Margins
Return on Capital
Free Cash Flow
See Also

Profitability Summary

Amryt Pharma Holdings Ltd's profitability score is 26/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Due Diligence Checks:
Positive Gross Profit
103.4m USD
Negative Operating Income
-23.3m USD
Negative Net Income
-87.5m USD
Negative Free Cash Flow
-89.1m USD
Positive 1-Year Revenue Growth
11%
Exceptional Revenue Growth Forecast
30%
View All
View All
Positive Gross Profit
103.4m USD
Negative Operating Income
-23.3m USD
Negative Net Income
-87.5m USD
Negative Free Cash Flow
-89.1m USD
Positive 1-Year Revenue Growth
11%
Exceptional Revenue Growth Forecast
30%
Negative ROE
-46%
Negative 3-Year Average ROE
-46%
ROE is Increasing
-49% > -46%
Negative ROIC
-3%
Negative 3-Year Average ROIC
-284%
ROIC is Increasing
-4% > -3%
Hide
Collapse
26/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Due Diligence Checks:
Positive Gross Profit
103.4m USD
Negative Operating Income
-23.3m USD
Negative Net Income
-87.5m USD
Negative Free Cash Flow
-89.1m USD
Positive 1-Year Revenue Growth
11%
Exceptional Revenue Growth Forecast
30%
View All
View All
Positive Gross Profit
103.4m USD
Negative Operating Income
-23.3m USD
Negative Net Income
-87.5m USD
Negative Free Cash Flow
-89.1m USD
Positive 1-Year Revenue Growth
11%
Exceptional Revenue Growth Forecast
30%
Negative ROE
-46%
Negative 3-Year Average ROE
-46%
ROE is Increasing
-49% > -46%
Negative ROIC
-3%
Negative 3-Year Average ROIC
-284%
ROIC is Increasing
-4% > -3%
Hide
Collapse
26/100
Profitability
Score
26/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less
0
Revenue
+0%
3Y
-
5Y
-
10Y
+27 563%
0
Operating Income
+0%
3Y
-
5Y
-
10Y
-2 713%
0
Net Income
+0%
3Y
-
5Y
-
10Y
-37 959%

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less
0
Gross Margin
0
Operating Margin
0
Net Margin

Earnings Waterfall
Amryt Pharma Holdings Ltd

Revenue
210.2m USD
Cost of Revenue
-106.8m USD
Gross Profit
103.4m USD
Operating Expenses
-126.8m USD
Operating Income
-23.3m USD
Other Expenses
-64.2m USD
Net Income
-87.5m USD

Margins Comparison
Amryt Pharma Holdings Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Amryt Pharma Holdings Ltd
LSE:AMYT
453.2m GBP
49%
-11%
-42%
US
Eli Lilly and Co
NYSE:LLY
734.9B USD
82%
40%
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
3%
-4%
US
Johnson & Johnson
NYSE:JNJ
366.6B USD
68%
26%
24%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
84%
45%
35%
CH
Roche Holding AG
SIX:ROG
208.1B CHF
74%
33%
14%
CH
Novartis AG
SIX:NOVN
188.4B CHF
76%
33%
24%
UK
AstraZeneca PLC
LSE:AZN
158.5B GBP
82%
24%
14%
US
Merck & Co Inc
NYSE:MRK
199B USD
78%
34%
27%
IE
E
Endo International PLC
LSE:0Y5F
163.5B USD
68%
11%
-126%
US
Pfizer Inc
NYSE:PFE
137.5B USD
75%
27%
13%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less
0
ROE
0
ROA
0
ROCE
0
ROIC

Return on Capital Comparison
Amryt Pharma Holdings Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Amryt Pharma Holdings Ltd
LSE:AMYT
453.2m GBP
-46%
-13%
-4%
-3%
US
Eli Lilly and Co
NYSE:LLY
734.9B USD
78%
14%
38%
23%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
-2%
2%
2%
US
Johnson & Johnson
NYSE:JNJ
366.6B USD
30%
12%
18%
14%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
88%
27%
70%
30%
CH
Roche Holding AG
SIX:ROG
208.1B CHF
27%
9%
29%
20%
CH
Novartis AG
SIX:NOVN
188.4B CHF
33%
13%
26%
18%
UK
AstraZeneca PLC
LSE:AZN
158.5B GBP
20%
7%
18%
14%
US
Merck & Co Inc
NYSE:MRK
199B USD
39%
16%
25%
19%
IE
E
Endo International PLC
LSE:0Y5F
163.5B USD
70%
-51%
5%
6%
US
Pfizer Inc
NYSE:PFE
137.5B USD
9%
4%
10%
9%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less
0
Operating Cash Flow
+0%
3Y
-
5Y
-
10Y
-66 145%
0
Capital Expenditures
+0%
3Y
-
5Y
-
10Y
+14 615%
0
Free Cash Flow
+0%
3Y
-
5Y
-
10Y
-59 274%

See Also

Summary
AMYT intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMYT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMYT stock valuation using valuation multiples.
Wall Street Estimates
AMYT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMYT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 264,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Warning
AMYT is delisted

This means that the stock is removed from a stock exchange and can no longer be traded.

Delisting typically occurs when a stock no longer meets exchange requirements. Other reasons for delisting may include legal violations, bankruptcy, a decrease in the number of shareholders, and acquisition by another company.

Close
Alpha Spread
Become a more intelligent investor
Sign up with Google
OR
Sign up with email
Already have an account? Sign in
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Sign In
Become a more intelligent investor
Sign in with Google
OR
Sign in with email
Not a member? Sign Up
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Recently Viewed Most Popular Most Undervalued Wide Economic Moat High Profitability High Solvency
Amryt Pharma Holdings Ltd
LSE:AMYT
143 GBX
-11.73%
Jiangxi Guotai Group Co Ltd
SSE:603977
12.16 CNY
-1.3%

Companies most frequently analyzed and tracked by Alpha Spread users.

Johnson & Johnson
NYSE:JNJ
152.41 USD
0.26%
Berkshire Hathaway Inc
NYSE:BRK.A
730 939.9 USD
0.16%
Bank of America Corp
NYSE:BAC
47.12 USD
-0.72%
Mastercard Inc
NYSE:MA
550.32 USD
0.83%
UnitedHealth Group Inc
NYSE:UNH
309.11 USD
2.14%
Exxon Mobil Corp
NYSE:XOM
109.38 USD
-0.55%
View Most Popular Stocks Full List

Every business has a fair value, its true price. Where market price tells you the price other people are willing to pay, fair value shows the value of a stock based on an analysis of the company’s actual financials (such as cash balance, revenue, operating margin, etc).

Franklin Covey Co
NYSE:FC
23.38 USD
0.34%
Mohawk Industries Inc
NYSE:MHK
104.9 USD
1.5%
Ardmore Shipping Corp
NYSE:ASC
9.75 USD
-0.91%
ASGN Inc
NYSE:ASGN
50.16 USD
-0.16%
Skyworks Solutions Inc
NASDAQ:SWKS
74.8 USD
0.2%
Weatherford International PLC
NASDAQ:WFRD
50.08 USD
-0.04%
View Most Undervalued Stocks Full List

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term.

Johnson & Johnson
NYSE:JNJ
152.41 USD
0.26%
Bank of America Corp
NYSE:BAC
47.12 USD
-0.72%
Mastercard Inc
NYSE:MA
550.32 USD
0.83%
Salesforce Inc
NYSE:CRM
273.42 USD
0.99%
Abbvie Inc
NYSE:ABBV
182.31 USD
-2.4%
Home Depot Inc
NYSE:HD
368.74 USD
1.44%
View Wide Economic Moat Stocks Full List

Companies demonstrating exceptional profitability and efficient operations.

Arista Networks Inc
NYSE:ANET
99.39 USD
-2.17%
Deckers Outdoor Corp
NYSE:DECK
104.2 USD
2.23%
Visa Inc
NYSE:V
348.61 USD
0.75%
Texas Pacific Land Corp
NYSE:TPL
1 055.44 USD
-1.86%
KLA Corp
NASDAQ:KLAC
889.87 USD
-1.45%
Manhattan Associates Inc
NASDAQ:MANH
197.25 USD
1.56%
View High Profitability Stocks Full List

Companies with the lowest probability of bankruptcy.

Salesforce Inc
NYSE:CRM
273.42 USD
0.99%
Accenture PLC
NYSE:ACN
295.46 USD
-0.21%
ServiceNow Inc
NYSE:NOW
1 022.42 USD
1.09%
Spotify Technology SA
NYSE:SPOT
772.6 USD
-0.43%
EOG Resources Inc
NYSE:EOG
120.8 USD
-0.27%
Applied Materials Inc
NASDAQ:AMAT
183.21 USD
-0.17%
View High Solvency Stocks Full List
Stock Screener
Discover stocks tailored to your investment strategy.
Open Stock Screener
You don't have any saved screeners yet
Other Tools
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF
Discount Rate Calculator
Cost of Equity & WACC

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett
Create Your Free Account
Already have an account? Sign in
Gain access to the world’s leading value investing platform
Gain access to the world’s leading value investing platform

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.

Sign up with Google
OR
Create Free Account

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.